Maes, Michael, Ringel, Karl, Kubera, Marta et al. · Journal of affective disorders · 2012 · DOI
This study found that people with depression have more antibodies attacking serotonin (a brain chemical) compared to healthy people, especially those with severe depression. These antibodies were linked to higher inflammation, immune activation, fatigue, and cognitive problems. The more depressive episodes someone had experienced, the more likely they were to have these antibodies, suggesting that repeated depression may change the immune system over time.
ME/CFS patients frequently experience comorbid depression and report serotonin-related symptoms (cognitive dysfunction, mood changes). This study provides a mechanistic link between immune activation, autoimmunity, and serotonin dysfunction—pathways implicated in ME/CFS pathophysiology. Understanding whether similar anti-5-HT autoimmunity occurs in ME/CFS or contributes to depression in ME/CFS patients could inform treatment approaches.
This study does not prove that anti-5-HT antibodies *cause* depression; correlation does not establish causation. The findings are from depressed populations and cannot be directly generalized to ME/CFS without replication in that population. Cross-sectional design means temporal sequencing—whether antibodies precede or follow depression onset—cannot be determined.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →